首页 正文

PCSK9 inhibitors: a patent review 2018-2023

{{output}}
Introduction: Proprotein convertase subtilisin/kexin 9 (PCSK9) plays a crucial role in breaking down the hepatic low-density lipoprotein receptor (LDLR), thereby influencing the levels of circulating low-density lipoprotein chole... ...